KRT13 and non-small cell lung carcinoma: Finally, SERPINE1, FOSL, and KRT13 are upregulated in NSCLC cells isolated from human patients that progressed on systemic therapies vs. patients with treatment-naive or residual disease (Supplementary Fig. 7G, H)24.